Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Price, Quote, News and Overview

NASDAQ:BWAY - Nasdaq - US10501L1061 - ADR - Currency: USD

10.75  -0.53 (-4.7%)

BWAY Quote, Performance and Key Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (2/21/2025, 8:04:42 PM)

10.75

-0.53 (-4.7%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High11.79
52 Week Low4.61
Market Cap202.27M
Shares18.82M
Float15.66M
Yearly DividendN/A
Dividend YieldN/A
PE41.35
Fwd PE13.67
Earnings (Next)03-04 2025-03-04/amc
IPO12-24 2006-12-24


BWAY short term performance overview.The bars show the price performance of BWAY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

BWAY long term performance overview.The bars show the price performance of BWAY in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300 400

The current stock price of BWAY is 10.75 USD. In the past month the price decreased by -1.65%. In the past year, price increased by 78.28%.

BRAINSWAY LTD-ADR / BWAY Daily stock chart

BWAY Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About BWAY

Company Profile

BWAY logo image Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Company Info

BRAINSWAY LTD-ADR

19 Hartum Street, Bynet Building, 3Rd Fl, Har HaHotzvim

JERUSALEM 9777518 IL

CEO: Christopher R. von Jako

Employees: 106

Company Website: https://www.brainsway.com/

Investor Relations: http://investors.brainsway.com

Phone: 97225813140

BRAINSWAY LTD-ADR / BWAY FAQ

What is the stock price of BRAINSWAY LTD-ADR today?

The current stock price of BWAY is 10.75 USD. The price decreased by -4.7% in the last trading session.


What is the ticker symbol for BRAINSWAY LTD-ADR stock?

The exchange symbol of BRAINSWAY LTD-ADR is BWAY and it is listed on the Nasdaq exchange.


On which exchange is BWAY stock listed?

BWAY stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BRAINSWAY LTD-ADR stock?

7 analysts have analysed BWAY and the average price target is 0.08 USD. This implies a price decrease of -99.3% is expected in the next year compared to the current price of 10.75. Check the BRAINSWAY LTD-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BRAINSWAY LTD-ADR worth?

BRAINSWAY LTD-ADR (BWAY) has a market capitalization of 202.27M USD. This makes BWAY a Micro Cap stock.


How many employees does BRAINSWAY LTD-ADR have?

BRAINSWAY LTD-ADR (BWAY) currently has 106 employees.


What are the support and resistance levels for BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a support level at 10.41. Check the full technical report for a detailed analysis of BWAY support and resistance levels.


Is BRAINSWAY LTD-ADR (BWAY) expected to grow?

The Revenue of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 28.34% in the next year. Check the estimates tab for more information on the BWAY EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BRAINSWAY LTD-ADR (BWAY) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BRAINSWAY LTD-ADR (BWAY) stock pay dividends?

BWAY does not pay a dividend.


When does BRAINSWAY LTD-ADR (BWAY) report earnings?

BRAINSWAY LTD-ADR (BWAY) will report earnings on 2025-03-04, after the market close.


What is the Price/Earnings (PE) ratio of BRAINSWAY LTD-ADR (BWAY)?

The PE ratio for BRAINSWAY LTD-ADR (BWAY) is 41.35. This is based on the reported non-GAAP earnings per share of 0.26 and the current share price of 10.75 USD. Check the full fundamental report for a full analysis of the valuation metrics for BWAY.


What is the Short Interest ratio of BRAINSWAY LTD-ADR (BWAY) stock?

The outstanding short interest for BRAINSWAY LTD-ADR (BWAY) is 0.4% of its float. Check the ownership tab for more information on the BWAY short interest.


BWAY Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BWAY. When comparing the yearly performance of all stocks, BWAY is one of the better performing stocks in the market, outperforming 93.4% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BWAY Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BWAY. BWAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BWAY Financial Highlights

Over the last trailing twelve months BWAY reported a non-GAAP Earnings per Share(EPS) of 0.26. The EPS increased by 116.74% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.88%
ROA 2.08%
ROE 3.41%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%300%
Sales Q2Q%25.47%
EPS 1Y (TTM)116.74%
Revenue 1Y (TTM)34.17%

BWAY Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to BWAY. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 149.31% and a revenue growth 28.34% for BWAY


Ownership
Inst Owners5.22%
Ins Owners16.75%
Short Float %0.4%
Short Ratio1.03
Analysts
Analysts85.71
Price Target0.08 (-99.26%)
EPS Next Y149.31%
Revenue Next Year28.34%